jardiance glp 1 FDA says no to Lilly, Boehringer's in type diabetes Eli Lilly, Boehringer hit FDA
Description
In May, the company launched an online GLP-1 supply tracker as an interactive tool to give patients real-time insights on GLP-1 drug shortages

Complete your labs and receive a personalized plan tailored to your metabolic needs

If additional glycemic control is needed: Increase from 5 mg to 7.5 mg subcutaneously for 4 weeks and thereafter in 2.5 mg increments after at least 4 weeks on the current dose

It is potentially dangerous

35 As mentioned, in the absence of T2DM, nearly all glucose filtered through the glomeruli is reabsorbed via SGLTs

Most patients dont see meaningful, sustained weight loss until they reach 1 mg or higher
